Ty. Chou et al., C-MYC IS GLYCOSYLATED AT THREONINE-58, A KNOWN PHOSPHORYLATION SITE AND A MUTATIONAL HOT-SPOT IN LYMPHOMAS, The Journal of biological chemistry, 270(32), 1995, pp. 18961-18965
c-Myc is a helix-loop-helix leucine zipper phosphoprotein that heterod
imerizes with Max and regulates gene transcription in cell proliferati
on, cell differentiation, and programmed cell death, Previously, we de
monstrated that c-Myc is modified by O-linked N-acetylglucosamine (O-G
lcNAc) within or nearby the N-terminal transcriptional activation doma
in (Chou, T.-Y., Dang, C. V., and Hart, G. W. (1995) Proc, Natl, Acad,
Sci, U.S.A. 92, 4417-4421), In this paper, we identified the O-GlcNAc
attachment site(s) on c-Myc, c-Myc purified from sf9 insect cells was
trypsinized, and its GlcNAc moieties were enzymically labeled with [H
-3]galactose, The [H-3]galactose-labeled glycopeptides were isolated b
y reverse phase high performance liquid chromatography and then subjec
ted to gas-phase sequencing, manual Edman degradation, and laser desor
ption/ionization mass spectrometry. These analyses show that threonine
58, an in vivo phosphorylation site in the transactivation domain, is
the major O-GlcNAc glycosylation site of c-Myc. Mutation of threonine
58, frequently found in retroviral v-Myc proteins and in human Burkit
t and AIDS-related lymphomas, is associated with enhanced transforming
activity and tumorigenicity. The reciprocal glycosylation and phospho
rylation at this biologically significant amino acid residue may play
an important role in the regulation of the functions of c-Myc.